Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™
Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™ October 7, 2025 BioSeeker mapped more than 10,000 isolates and identified targetable r
Seek Labs VP of Research, Dr. Anindita Roy, Honored with 2025 Women Tech Council Rising Star Award
Seek Labs Vice President of Research, Dr. Anindita Roy, Honored with 2025 Women Tech Council Rising Star Award October 6, 2025 Seek Labs is proud to announce our Vice President of
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV) September 24, 2025 Salt Lake City, UT (Business Wire)
Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™
Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ to Advance Development of a Pan-Target, Programmable Therapeutic September 9, 2025 Salt Lake City, UT (Business Wire) –
Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform
Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform Built in a matter of months, Seek Labs’ functional investigationa
Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™
Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™, Accelerating Therapeutic Discovery for Chikungunya, West Nile Virus, and Zika August 5, 2025 Salt L
Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas
Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains July 22, 2025 SALT LA
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV) July 8, 2025 Read the Medium Article from our CEO, Jared Bauer
Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks
Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks June 23, 2025 Read the Medium Article from o
Seek Labs Unveils BioSeeker™
Seek Labs Unveils BioSeeker™ Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions June 10, 2025 R